“So we know that the FDA already told NP that ph
Post# of 145416
![Avatar](/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
NP did not say the FDA told him the phase 3 will be small. He’s assuming a phase 3 trial will require a small number of patients because of Leronlimab’s safety profile and the already statistically significant data from the M2M trial.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)